Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

HUTCHMED (China) Limited

HMDCFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$3.02
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

HUTCHMED (China) Limited (HMDCF) Stock Overview

Explore HUTCHMED (China) Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.6B
P/E Ratio5.66
EPS (TTM)$0.53
ROE0.47%
Fundamental Analysis

AI Price Forecasts

1 Month$3.08
3 Months$3.37
1 Year Target$3.37

HMDCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of HUTCHMED (China) Limited (HMDCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.88, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.37.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.66 and a market capitalization of 2.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-17.49%
6-Month Change
-5.63%
Year-to-Date (YTD) Change
-17.49%
1-Year Change
-5.63%
3-Year Change
-5.63%
5-Year Change
-40.90%
All-Time (Max) Change
874.19%

Contact Information

852 2128 1188
Cheung Kong Center, Hong Kong, NaN, NaN

Company Facts

18,110 Employees
IPO DateApr 17, 2014
CountryHK
Actively Trading

Frequently Asked Questions